Skip to main content
SpringerLink
Log in

The Role of Surgery

  • Chapter
  • First Online:
Diffuse Gastric Cancer

  • 349 Accesses

Abstract

Gastric adenocarcinoma can be divided into intestinal and diffuse, according to Lauren’s classification. Pathological aspects were discussed previously regarding this grouping. The same was done with respect to the biological behavior of these tumors, with diffuse adenocarcinoma presenting a more aggressive behavior comparing to the intestinal type. Essentially, such behavior is the major impact factor in surgical treatment, especially in endoscopic management. Regardless of its classification, the curative treatment of gastric cancer necessarily involves endoscopic resection or surgery even with the several options of neoadjuvant and adjuvant treatment that are available. This chapter describes the surgical management of diffuse gastric cancer, an aggressive disease, and its peculiarities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.

    Article  Google Scholar 

  2. De Manzoni G, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M, Donini A, Fumagalli U, Mazzei MA, Pacelli F. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20:20–30.

    Article  PubMed  Google Scholar 

  3. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C, International Gastric Cancer Linkage C. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Anold D, on behalf of the ESMO Guidelines Committe. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27(Supplement 5):v38–49. https://doi.org/10.1093/annonc/mdw350.

    Article  PubMed  CAS  Google Scholar 

  5. Wang SY, Yeh CN, Lee HL, et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol. 2009;16:2738–43.

    Article  PubMed  Google Scholar 

  6. Sun Z, Li DM, Wang ZN, et al. Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol. 2009;16:3028–37.

    Article  PubMed  Google Scholar 

  7. Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20:2663–8.

    Article  CAS  PubMed  Google Scholar 

  8. Squires MH 3rd, Kooby DA, Pawlik DA, et al. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-institution study of the US Gastric Cancer Collaborative. Ann Surg Oncol. 2014;21:4202–10.

    Article  PubMed  Google Scholar 

  9. Marrelli D, Pedrazzani C, Morgagni P, de Manzoni G, Pacelli F, Coniglio A, et al. Italian Research Group for Gastric Cancer. Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011;98:1273–83.

    Google Scholar 

  10. Shen P, Stewart JH, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale. Curr Probl Cancer. 2009;33:125–41.

    Article  PubMed  Google Scholar 

  11. Roviello F, Caruso S, Neri A, Marrelli D. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol. 2013;39:1309–16.

    Article  CAS  PubMed  Google Scholar 

  12. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, Bereder JM, Lorimier G, Quenet F, Elias D. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370–7.

    Article  PubMed  Google Scholar 

  13. Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: where are we going? World J Gastroenterol. 2015;21(26):7954–69.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bozzetti F, Yu W, Baratti D, Kusamura S, Deraco M. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol. 2008;98:273–6.

    Article  CAS  PubMed  Google Scholar 

  15. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg. 2005;92:370–5.

    Article  CAS  PubMed  Google Scholar 

  16. Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol. 2004;10:2727–30.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.

    Article  PubMed  Google Scholar 

  18. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol. 2006;60:273–7.

    Article  CAS  PubMed  Google Scholar 

  19. Zilberstein B, Malheiros C, Lourenço LG, Kassab P, Jacob CE, Weston AC, Bresciani CJC, Castro O, Gama-Rodrigues J, de Consenso G. Consenso brasileiro sobre câncer gástrico: diretrizes para o câncer gástrico no Brasil. ABCD Arq Bras Cir Dig. 2013;26(1):2–6.

    Article  PubMed  Google Scholar 

  20. Moehler M, Baltin CTH, Ebert M, Fischbach W, Gockel I, Grenacher L, et al. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer. 2015;18:550–63.

    Article  PubMed  Google Scholar 

  21. Kim W, Kim HH, Han SU, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg. 2016;263:28–35.

    Article  PubMed  Google Scholar 

  22. Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol. 2016;34:1350–7. https://doi.org/10.1200/JCO.2015.63.7215.

    Article  PubMed  Google Scholar 

  23. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995;7:619–27.

    Article  CAS  PubMed  Google Scholar 

  24. Geisbrecht ER, Montell DJ. Myosin VI is required for E-cadherin-mediated border cell migration. Nat Cell Biol. 2002;4:616–20.

    Article  CAS  PubMed  Google Scholar 

  25. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525–8.

    Article  CAS  PubMed  Google Scholar 

  26. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chen Y, Kingham K, Ford JM, et al. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011;18:2594–8.

    Article  PubMed  Google Scholar 

  29. Wang Z, Xu J, Shi Z, Shen X, Luo T, Bi J, Nie M. Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol. 2016;51(9):1043–9.

    Article  PubMed  Google Scholar 

  30. Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–62.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46(6):1101–10.

    Article  CAS  PubMed  Google Scholar 

  33. Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current perspectives on gastric Cancer. Gastroenterol Clin N Am. 2016;45(3):413–28.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of São Paulo School of Medicine, Instituto do Câncer do Estado de São Paulo, ICESP-HCFMUSP, São Paulo, SP, Brazil

    Ulysses Ribeiro Jr.

  2. Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP, Brazil

    Fernando Simionato Perrotta

Authors
  1. Ulysses Ribeiro Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Simionato Perrotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulysses Ribeiro Jr. .

Editor information

Editors and Affiliations

  1. Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, Brazil

    Tiago Biachi de Castria

  2. CLION, Salvador, Bahia, Brazil

    Rodrigo Santa Cruz Guindalini

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ribeiro, U., Perrotta, F.S. (2018). The Role of Surgery. In: de Castria, T., Guindalini, R. (eds) Diffuse Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-95234-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95234-5_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95233-8

  • Online ISBN: 978-3-319-95234-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation